BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19648167)

  • 21. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.
    Morris E; Thomson K; Craddock C; Mahendra P; Milligan D; Cook G; Smith GM; Parker A; Schey S; Chopra R; Hatton C; Tighe J; Hunter A; Peggs K; Linch D; Goldstone A; Mackinnon S
    Blood; 2004 Dec; 104(13):3865-71. PubMed ID: 15304395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission.
    Pidala J; Djulbegovic B; Anasetti C; Kharfan-Dabaja M; Kumar A
    Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD008818. PubMed ID: 21975786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Onishi Y; Sasaki O; Ichikawa S; Inokura K; Katsuoka Y; Ohtsuka Ohba R; Okitsu Y; Kohata K; Ohguchi H; Fukuhara N; Yokoyama H; Yamada MF; Yamamoto J; Ishizawa K; Kameoka J; Harigae H
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1093-7. PubMed ID: 21277378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.
    Faulkner RD; Craddock C; Byrne JL; Mahendra P; Haynes AP; Prentice HG; Potter M; Pagliuca A; Ho A; Devereux S; McQuaker G; Mufti G; Yin JL; Russell NH
    Blood; 2004 Jan; 103(2):428-34. PubMed ID: 12969983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
    Tomblyn MB; Arora M; Baker KS; Blazar BR; Brunstein CG; Burns LJ; DeFor TE; Dusenbery KE; Kaufman DS; Kersey JH; MacMillan ML; McGlave PB; Miller JS; Orchard PJ; Slungaard A; Tomblyn MR; Vercellotti GM; Verneris MR; Wagner JE; Weisdorf DJ
    J Clin Oncol; 2009 Aug; 27(22):3634-41. PubMed ID: 19581540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.
    Das-Gupta EP; Russell NH; Shaw BE; Pearce RM; Byrne JL
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):724-33. PubMed ID: 17531783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
    Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty years' experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group.
    Iida H; Sao H; Kitaori K; Gotoh S; Yazaki M; Kojima S; Wakita A; Morishima Y; Kodera Y; Morishita Y
    Int J Hematol; 2004 Jan; 79(1):79-84. PubMed ID: 14979483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Nishiwaki S; Miyamura K; Ohashi K; Kurokawa M; Taniguchi S; Fukuda T; Ikegame K; Takahashi S; Mori T; Imai K; Iida H; Hidaka M; Sakamaki H; Morishima Y; Kato K; Suzuki R; Tanaka J;
    Ann Oncol; 2013 Jun; 24(6):1594-602. PubMed ID: 23372050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
    Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
    van Besien K; Artz A; Smith S; Cao D; Rich S; Godley L; Jones D; Del Cerro P; Bennett D; Casey B; Odenike O; Thirman M; Daugherty C; Wickrema A; Zimmerman T; Larson RA; Stock W
    J Clin Oncol; 2005 Aug; 23(24):5728-38. PubMed ID: 16009946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation.
    Kanda Y; Oshima K; Asano-Mori Y; Kandabashi K; Nakagawa M; Sakata-Yanagimoto M; Izutsu K; Hangaishi A; Tsujino S; Ogawa S; Motokura T; Chiba S; Hirai H
    Transplantation; 2005 May; 79(10):1351-7. PubMed ID: 15912103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.
    Piemontese S; Ciceri F; Labopin M; Bacigalupo A; Huang H; Santarone S; Gorin NC; Koc Y; Wu D; Beelen D; Tischer J; Ehninger G; Arcese W; Nagler A; Mohty M;
    Leukemia; 2015 May; 29(5):1069-75. PubMed ID: 25434302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission.
    Eom KS; Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Park CW; Lee S
    Am J Hematol; 2013 Aug; 88(8):634-41. PubMed ID: 23620000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
    Kebriaei P; Saliba R; Rondon G; Chiattone A; Luthra R; Anderlini P; Andersson B; Shpall E; Popat U; Jones R; Worth L; Ravandi F; Thomas D; O'Brien S; Kantarjian H; de Lima M; Giralt S; Champlin R
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):584-92. PubMed ID: 21867666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.